Everest Organics starts making ingredient for Merck’s COVID-19 pill Reuters Oct 13, 2021 The bulk drugs manufacturer joins Divi's Laboratories as an API maker for Merck's experimental oral drug
Divi’s Laboratories commence construction of facility near Kakinada EP News Bureau Dec 2, 2020 The company will be investing about Rs 1500 crores for the implementation of the facility
US health regulator to soon lift import alert imposed on Divi’s Laboratories EP News Bureau Jul 10, 2017 Divi’s said it has taken up appropriate remediation measures to address the concerns raised by USFDA
